Gene Mapping for Stargardt's Macular Degeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2002 - March 31, 2003
Grant ID
M2002040
Summary
Stargardt’s macular dystrophy (STGD) is a common childhood-onset form of macular dystrophy characterized by the progressive loss of central vision during the first and second decades of life. STGD has been genetically linked to age-related macular degeneration (AMD). Dr. Zhang is performing a genetic study of three large families affected with STGD to identify the underlying disease-causing gene(s). His preliminary data excluded any known genes previously associated with STGD as playing a role in the disease in these families. He is now continuing his investigation using standard genomic methodology to identify new gene(s) that may be involved in Stargardt’s macular dystrophy. The identification of new genes that are responsible for a disease is a key step towards understanding its pathogenesis. The natural history and clinical features of the disease can then be investigated for diagnostic purposes. The discovery of these genes will also help to identify family members who might be at risk for the disease before it strikes and provide information for designing new treatments.
Grants
Related Grants
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Krishna Singh, PhD
Current Organization
Johns Hopkins University School of Medicine
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Krishna Singh, PhD
Current Organization
Johns Hopkins University School of Medicine
Macular Degeneration Research
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shintaro Shirahama, MD, PhD
Current Organization
Schepens Eye Research Institute of Massachusetts Eye and Ear
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shintaro Shirahama, MD, PhD
Current Organization
Schepens Eye Research Institute of Massachusetts Eye and Ear